{"transactions":[{"id":728815,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2026-06-23T13:29:05.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan.  The restricted stock units vest in four equal annual installments beginning on June 30, 2023.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan.  The restricted stock units vest in four equal annual installments beginning on June 30, 2023.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001253497-26-000005","document":"wk-form4_1782221342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349726000005/wk-form4_1782221342.xml","form_type":"4"}},{"id":728814,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-23T13:29:05.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2319,"price":92.2,"value":213811.8,"ownership":{"direct":true},"balance_after":11937,"source":{"system":"sec-edgar","filing":"0001253497-26-000005","document":"wk-form4_1782221342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349726000005/wk-form4_1782221342.xml","form_type":"4"}},{"id":728813,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-23T13:29:05.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5796,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."}],"balance_after":14256,"source":{"system":"sec-edgar","filing":"0001253497-26-000005","document":"wk-form4_1782221342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349726000005/wk-form4_1782221342.xml","form_type":"4"}},{"id":858137,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T19:42:24.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":8907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 7, 2026.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 7, 2026.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":8907,"derivative":{"underlying":"Common Stock","underlying_shares":8907},"source":{"system":"sec-edgar","filing":"0001253497-26-000002","document":"form4-03052026_070321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349726000002/form4-03052026_070321.xml","form_type":"4"}},{"id":971053,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-12T22:00:16.000Z","date":"2025-12-11","kind":"exercise","planned":false,"acquired":false,"shares":1812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":3624,"derivative":{"underlying":"Common Stock","underlying_shares":1812},"source":{"system":"sec-edgar","filing":"0001253497-25-000015","document":"form4-12122025_051211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000015/form4-12122025_051211.xml","form_type":"4"}},{"id":971052,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-12T22:00:16.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":714,"price":97.38,"value":69529.32,"ownership":{"direct":true},"balance_after":8460,"source":{"system":"sec-edgar","filing":"0001253497-25-000015","document":"form4-12122025_051211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000015/form4-12122025_051211.xml","form_type":"4"}},{"id":971051,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-12T22:00:16.000Z","date":"2025-12-11","kind":"exercise","planned":false,"acquired":true,"shares":1812,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9174,"source":{"system":"sec-edgar","filing":"0001253497-25-000015","document":"form4-12122025_051211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000015/form4-12122025_051211.xml","form_type":"4"}},{"id":971050,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-12T22:00:16.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":532,"price":98.09,"value":52183.88,"ownership":{"direct":true},"balance_after":7362,"source":{"system":"sec-edgar","filing":"0001253497-25-000015","document":"form4-12122025_051211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000015/form4-12122025_051211.xml","form_type":"4"}},{"id":971049,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-12T22:00:16.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":14468,"price":97.26,"value":1407157.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7894,"source":{"system":"sec-edgar","filing":"0001253497-25-000015","document":"form4-12122025_051211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000015/form4-12122025_051211.xml","form_type":"4"}},{"id":974338,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Performance-based Restricted Stock Units","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"exercise","planned":false,"acquired":false,"shares":21008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 7, 2022, the reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On December 7, 2022, the reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21008},"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":974337,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"exercise","planned":false,"acquired":false,"shares":10504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received restricted stock units (\"RSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  The RSUs vest in full on the third anniversary of the grant date, December 7, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received restricted stock units (\"RSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  The RSUs vest in full on the third anniversary of the grant date, December 7, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10504},"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":974336,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":8267,"price":94.57,"value":781810.19,"ownership":{"direct":true},"balance_after":22362,"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":974335,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"exercise","planned":false,"acquired":true,"shares":21008,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."}],"balance_after":30629,"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":974334,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3383,"price":94.57,"value":319930.31,"ownership":{"direct":true},"balance_after":9621,"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":974333,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-10T22:00:09.000Z","date":"2025-12-07","kind":"exercise","planned":false,"acquired":true,"shares":10504,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":13004,"source":{"system":"sec-edgar","filing":"0001253497-25-000010","document":"form4-12102025_051204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000010/form4-12102025_051204.xml","form_type":"4"}},{"id":1001847,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-12T21:00:05.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":10651,"price":84.5143,"value":900161.8093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $84.25 to $85.18. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001253497-25-000008","document":"form4-11122025_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000125349725000008/form4-11122025_041101.xml","form_type":"4"}},{"id":1103609,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-06-24T00:00:21.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":5796,"derivative":{"underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001415889-25-018013","document":"form4-06232025_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925018013/form4-06232025_080616.xml","form_type":"4"}},{"id":1103608,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-24T00:00:21.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1412,"price":58.24,"value":82234.88,"ownership":{"direct":true},"balance_after":13151,"source":{"system":"sec-edgar","filing":"0001415889-25-018013","document":"form4-06232025_080616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925018013/form4-06232025_080616.xml","form_type":"4"}},{"id":1103607,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-24T00:00:21.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5796,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."}],"balance_after":14563,"source":{"system":"sec-edgar","filing":"0001415889-25-018013","document":"form4-06232025_080616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925018013/form4-06232025_080616.xml","form_type":"4"}},{"id":1176509,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-07T20:10:04.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"When vested, restricted stock units (\"RSUs\") are convertible into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"On April 4, 2025, the Reporting Person filed a Form 4, which inadvertently stated in Column 5 of Table II that 5,796 RSUs were acquired instead of disposed. This inadvertent misstatement has been corrected in this amended filing to note that 5,796 RSUs were disposed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":11592,"derivative":{"exercise_date":"2024-06-20","underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001415889-25-010289","document":"form4a-04072025_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925010289/form4a-04072025_040401.xml","form_type":"4/A","original_submission_date":"2025-04-04"}},{"id":1177513,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-04T20:45:05.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":11592,"derivative":{"exercise_date":"2024-06-20","underlying":"Common Stock","underlying_shares":5796},"source":{"system":"sec-edgar","filing":"0001415889-25-010210","document":"form4-04042025_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925010210/form4-04042025_040401.xml","form_type":"4"}},{"id":1177512,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-04T20:45:05.000Z","date":"2024-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1412,"price":42.53,"value":60052.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction."}],"balance_after":8767,"source":{"system":"sec-edgar","filing":"0001415889-25-010210","document":"form4-04042025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925010210/form4-04042025_040401.xml","form_type":"4"}},{"id":1177511,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-04T20:45:05.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5796,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units (\"RSUs\") on a one-for-one basis."}],"balance_after":10179,"source":{"system":"sec-edgar","filing":"0001415889-25-010210","document":"form4-04042025_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588925010210/form4-04042025_040401.xml","form_type":"4"}},{"id":1332177,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Performance-based Restricted Stock Units","published_at":"2024-12-13T21:00:04.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":5435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2023 Equity Incentive Plan.  PRSUs convert into common stock on a one-for-one basis.  The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2023 Equity Incentive Plan.  PRSUs convert into common stock on a one-for-one basis.  The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2023 Equity Incentive Plan.  PRSUs convert into common stock on a one-for-one basis.  The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index."}],"balance_after":23119,"derivative":{"underlying":"Common Stock","underlying_shares":5435},"source":{"system":"sec-edgar","filing":"0001415889-24-029268","document":"form4-12132024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588924029268/form4-12132024_041201.xml","form_type":"4"}},{"id":1332176,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-12-13T21:00:04.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":5436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.  The RSUs vest in three equal annual installments beginning on December 11, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":40508,"derivative":{"underlying":"Common Stock","underlying_shares":5436},"source":{"system":"sec-edgar","filing":"0001415889-24-029268","document":"form4-12132024_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588924029268/form4-12132024_041201.xml","form_type":"4"}},{"id":1347068,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-03T02:00:06.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":54.1797,"value":135449.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $54.00 to $54.22. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4383,"source":{"system":"sec-edgar","filing":"0001415889-24-028036","document":"form4-12022024_091202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588924028036/form4-12022024_091202.xml","form_type":"4"}},{"id":1716179,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Performance-based Restricted Stock Units","published_at":"2023-12-11T23:00:25.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":7180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2023 through December 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"If the relative measure at December 7, 2026 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2023 through December 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"If the relative measure at December 7, 2026 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested."}],"balance_after":17684,"derivative":{"underlying":"Common Stock","underlying_shares":7180},"source":{"system":"sec-edgar","filing":"0001415889-23-016253","document":"form4-12112023_061212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588923016253/form4-12112023_061212.xml","form_type":"4"}},{"id":1716178,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-12-11T23:00:25.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":7180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units (\"RSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  The RSUs vest in full on the third anniversary of the grant date, December 7, 2026.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units (\"RSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  The RSUs vest in full on the third anniversary of the grant date, December 7, 2026.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":35072,"derivative":{"underlying":"Common Stock","underlying_shares":7180},"source":{"system":"sec-edgar","filing":"0001415889-23-016253","document":"form4-12112023_061212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588923016253/form4-12112023_061212.xml","form_type":"4"}},{"id":1846359,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-06-22T20:30:13.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 20, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 20, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":17388,"derivative":{"exercise_date":"2023-06-20","underlying":"Common Stock","underlying_shares":5795},"source":{"system":"sec-edgar","filing":"0001415889-23-010149","document":"form4-06222023_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588923010149/form4-06222023_040601.xml","form_type":"4"}},{"id":1846358,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-06-22T20:30:13.000Z","date":"2023-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1412,"price":47.88,"value":67606.56,"ownership":{"direct":true},"balance_after":6883,"source":{"system":"sec-edgar","filing":"0001415889-23-010149","document":"form4-06222023_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588923010149/form4-06222023_040601.xml","form_type":"4"}},{"id":1846357,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2023-06-22T20:30:13.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5795,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8295,"source":{"system":"sec-edgar","filing":"0001415889-23-010149","document":"form4-06222023_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000141588923010149/form4-06222023_040601.xml","form_type":"4"}},{"id":2083534,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-16T18:10:47.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":2500,"price":28.6703,"value":71675.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $28.61 to $28.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0000898432-22-000666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000666/form4.xml","form_type":"4"}},{"id":2091032,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2022-12-09T15:43:58.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":10504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2022 through December 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100% and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person received performance-based restricted stock units (\"PRSUs\") under Iradimed Corporation's 2014 Equity Incentive Plan.  Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2022 through December 7, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100% and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested."}],"balance_after":10504,"derivative":{"underlying":"Common Stock","underlying_shares":10504},"source":{"system":"sec-edgar","filing":"0000898432-22-000660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000660/form4.xml","form_type":"4"}},{"id":2091031,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-09T15:43:58.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":10504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2025.  Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":33687,"derivative":{"underlying":"Common Stock","underlying_shares":10504},"source":{"system":"sec-edgar","filing":"0000898432-22-000660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000660/form4.xml","form_type":"4"}},{"id":2209803,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-08T21:01:23.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":23183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Form 4/A is being filed solely to correct administrative errors in (i) the number of shares of Common Stock underlying Restricted Stock Units shown as acquired and beneficially held by the reporting person and (ii) the vesting commencement date of such Restricted Stock Units in his Form 4 filed on June 23, 2022 (the \"Original Form 4\"). All other information set forth in the Original Form 4 remains correct."}],"balance_after":23183,"derivative":{"underlying":"Common Stock","underlying_shares":23183},"source":{"system":"sec-edgar","filing":"0000898432-22-000462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000462/form4.xml","form_type":"4/A","original_submission_date":"2022-06-23"}},{"id":2222944,"issuer":{"id":4896,"kind":"organization","name":"IRADIMED CORP","symbol":"IRMD"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-23T12:35:00.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":23.183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":23.183,"derivative":{"underlying":"Common Stock","underlying_shares":23.183},"source":{"system":"sec-edgar","filing":"0000898432-22-000409","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000409/form4.xml","form_type":"4"}},{"id":2316433,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-28T20:52:54.000Z","date":"2022-03-22","kind":"sale","acquired":false,"shares":3462,"price":2.8197,"value":9761.8014,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request."}],"balance_after":35130,"source":{"system":"sec-edgar","filing":"0001209191-22-021330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919122021330/doc4.xml","form_type":"4"}},{"id":2381822,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-23T00:23:43.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":14596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022."}],"balance_after":38592,"source":{"system":"sec-edgar","filing":"0001209191-22-011950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919122011950/doc4.xml","form_type":"4"}},{"id":2805545,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-05T21:41:44.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":13015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\")."},{"field":"date","element":"transactionDate","label":"F2","text":"The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021."},{"field":"shares","element":"transactionShares","label":"F3","text":"The grant consists of RSUs that vest annually over three years."}],"balance_after":23996,"source":{"system":"sec-edgar","filing":"0001209191-21-018246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919121018246/doc4.xml","form_type":"4"}},{"id":3185991,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-02T20:54:33.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant of the RSUs was approved by the compensation committee of the company's board of directors on November 6, 2019 contingent upon (a) approval by the company's stockholders at the next occurring special or annual meeting of the stockholders (to increase the number of shares reserved for issuance under the company's Amended and Restated 2014 Equity Incentive Plan to accommodate the grants of the RSUs), which approval was obtained at a special meeting of the stockholders on March 12, 2020, and (b) the company filing a registration statement on Form S-8 with the Securities and Exchange Commission (the \"SEC\") to register the offer and sale of the shares underlying the RSUs, which registration statement was filed with the SEC on April 1, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The grant consists of restricted stock units (\"RSUs\") that vest as to one quarter (1/4th) of the total number listed above on November 15, 2020, and as to an additional one quarter (1/4th) of the total number of RSUs listed above on November 15 of each following year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"After taking into account the 1-for-15 reverse stock split effective March 24, 2020."}],"balance_after":10981,"source":{"system":"sec-edgar","filing":"0001209191-20-022637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919120022637/doc4.xml","form_type":"4"}},{"id":3376183,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-08T23:03:29.000Z","date":"2019-11-06","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 1/48th of the total number of shares on December 6, 2019 and thereafter as to 1/48th of the total number of shares on the same day of each month."}],"balance_after":640000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-11-06","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-19-055863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919119055863/doc4.xml","form_type":"4"}},{"id":3483843,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-19T17:48:33.000Z","date":"2019-05-31","kind":"sale","acquired":false,"shares":10292,"price":1.37,"value":14100.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the filer to satisfy the tax obligations of the filer in connection with a grant of common stock on April 24, 2019 in lieu of cash payment of bonus for services performed in 2018."}],"balance_after":4708,"source":{"system":"sec-edgar","filing":"0001209191-19-037946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919119037946/doc4.xml","form_type":"4"}},{"id":3547486,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-26T21:11:50.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were awarded in lieu of cash payment of bonus for services performed as an executive officer in 2018."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-19-026248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919119026248/doc4.xml","form_type":"4"}},{"id":3827088,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":35950,"kind":"person","name":"GLENN JOHN","position":1,"cik":"0001253497","reported_name":"GLENN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-04T21:26:05.000Z","date":"2018-08-31","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 25% of the total number of shares on August 31, 2019 and thereafter vests in equal monthly installments for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":2.68,"expiration_date":"2028-08-31","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-18-049259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253497/000120919118049259/doc4.xml","form_type":"4"}}]}